OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ARVN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Arvinas (ARVN) Earnings Date & Reports

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ARVN is expected to report earnings to fall 4.95% to -79 cents per share on November 11

Q3'25

Est.

$-0.80

Q2'25

Beat

by $0.10

Q1'25

Beat

by $2.14

Q4'24

Beat

by $0.33

Q3'24

Beat

by $0.16

The last earnings report on August 06 showed earnings per share of -83 cents, beating the estimate of -93 cents. With 216.83K shares outstanding, the current market capitalization sits at 519.80M.

View a ticker or compare two or three

Compare

ARVN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ARVN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ARVN showed earnings on August 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of therapies to degrade disease-causing proteins

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

395 Winchester Avenue

Phone

+1 203 535-1456

Employees

445

Web

https://www.arvinas.com